lobbying_activities: 3138218
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3138218 | ac3c909e-5777-49f5-9de9-f25544aa3c1d | 1T | BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | 5153 | REASON FOR HOPE | 2024 | first_quarter | HCR | H.R.1393/S.689 - Breakthrough Therapies Act; issues related to psychedelic-assisted therapy | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2024-03-05T15:06:22-05:00 |